Bayer Rapid Relief
- Product NDC
- 0280-0103
- 11-digit product format
- 002800103
- Labeler code
- 0280
- Product ID
- 0280-0103_45372de8-2f8f-007c-e063-6294a90a4f7b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin/Caffeine Oral Powder
- Dosage form
- POWDER
- Route
- ORAL
- Labeler
- Bayer HealthCare LLC.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-01-13
- Substance
- CAFFEINE; ASPIRIN
- Active strength
- 65; 650 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 21:27 UTC · source 2025-12-05 | unfinished product | product | a6255e0c9aa5… | a0211a219f2e… | |
| 2025-12-14 21:27 UTC · source 2025-12-05 | unfinished package | package | 0280-0103-04 | a6255e0c9aa5… | a0211a219f2e… |
| 2025-08-26 23:59 UTC · source 2025-08-26 | unfinished product | product | 1d862106b807… | 00c93037cd84… | |
| 2025-08-26 23:59 UTC · source 2025-08-26 | unfinished package | package | 0280-0103-04 | 1d862106b807… | 00c93037cd84… |
| 2025-05-15 14:59 UTC · source 2025-05-14 | unfinished product | product | 390b4c401c3f… | 2c692c2daee3… | |
| 2025-05-15 14:59 UTC · source 2025-05-14 | unfinished package | package | 0280-0103-04 | 390b4c401c3f… | 2c692c2daee3… |
| 2025-04-01 07:37 UTC · source 2025-03-31 | unfinished product | product | e30019b0c005… | a3f0b14938b7… | |
| 2025-04-01 07:37 UTC · source 2025-03-31 | unfinished package | package | 0280-0103-04 | e30019b0c005… | a3f0b14938b7… |
| 2025-03-01 13:19 UTC · source 2025-02-28 | unfinished product | product | bbbc9f937eca… | 946b9c97cf81… | |
| 2025-03-01 13:19 UTC · source 2025-02-28 | unfinished package | package | 0280-0103-04 | bbbc9f937eca… | 946b9c97cf81… |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished product | product | f268b84574a6… | 26285f5ac5df… | |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished package | package | 0280-0103-04 | f268b84574a6… | 26285f5ac5df… |
| 2025-02-01 13:13 UTC · source 2025-01-31 | unfinished product | product | f764e8902f78… | 92046438deef… | |
| 2025-02-01 13:13 UTC · source 2025-01-31 | unfinished package | package | 0280-0103-04 | f764e8902f78… | 92046438deef… |
| 2025-01-20 13:05 UTC · source 2025-01-17 | unfinished product | product | 68b1e3bced9e… | 98a755eb8bc6… | |
| 2025-01-20 13:05 UTC · source 2025-01-17 | unfinished package | package | 0280-0103-04 | 68b1e3bced9e… | 98a755eb8bc6… |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished product | product | 05c55d027831… | ca05dca9dc4c… | |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished package | package | 0280-0103-04 | 05c55d027831… | ca05dca9dc4c… |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished product | product | 48b4f40e6753… | c7c7a00d2afa… | |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished package | package | 0280-0103-04 | 48b4f40e6753… | c7c7a00d2afa… |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished product | product | 27f29a85d7e4… | 1372111e901f… | |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished package | package | 0280-0103-04 | 27f29a85d7e4… | 1372111e901f… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bayer Rapid Relief
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CAFFEINE | 65 mg/1 |
| ASPIRIN | 650 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3G6A5W338E | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2626726 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f1fecbb0-5b55-fe8f-e053-2995a90a0977 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0280-0103-01 | Bayer Rapid Relief | 10 in 1 PACKET | POWDER | 10 | 10 | |
| 0280-0103-01 | Bayer Rapid Relief | 1 in 1 CARTON | POWDER | 1 | 10 | |
| 0280-0103-02 | Bayer Rapid Relief | 1 in 1 CARTON | POWDER | 1 | 10 | |
| 0280-0103-02 | Bayer Rapid Relief | 20 in 1 PACKET | POWDER | 20 | 10 | |
| 0280-0103-03 | Bayer Rapid Relief | 1 in 1 CARTON | POWDER | 1 | 10 | |
| 0280-0103-03 | Bayer Rapid Relief | 30 in 1 PACKET | POWDER | 30 | 10 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0280-0103-01 | EA - Each | 0280-0103 | d9b59d60-ff18-4c1a-aa0d-b8d47e998a51 | 1 | 2025-05-14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Menstrual Relief Maximum Strength | ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE | United Natural Foods, Inc. dba UNFI | 807598ef-9f03-48df-b076-3ee95ef4b06c | 2026-01-05 | Warnings | M013 |
| Pain Relief Extra Strength, Non-Aspirin | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC | 1fb5e871-45fd-46fe-bf73-5192f8316e8e | 2026-01-02 | Warnings | M013 |
| Pain Reliever Extra Strength | ACETAMINOPHEN | Valu Merchandisers Company | 0005aafa-08f8-4990-a54d-cc097195708f | 2026-01-02 | Warnings | M013 |
| Extra Strength Pain Reliever | ACETAMINOPHEN | Walmart Inc. | 152bb455-da5b-ae13-e063-6394a90acab0 | 2026-01-01 | Warnings | M013 |
| Dr. Cocoa for Children Pain and Fever | ACETAMINOPHEN | Infirst Healthcare Inc. | 486ea294-6d18-a907-e063-6294a90ad284 | 2026-01-01 | Warnings | M013 |
| ED APAP | ACETAMINOPHEN | EDWARDS PHARMACEUTICALS, INC. | f76d5fff-ebea-40f9-aad3-4064a0c863f0 | 2025-12-31 | Warnings | M013 |
| EXTRA STRENGTH PAIN RELIEF | ACETAMINOPHEN | GERI-CARE PHARMACEUTICAL CORP | 99ec63ef-aa28-c2fb-e053-2a95a90a9f6d | 2025-12-31 | Warnings | M013 |
| Puregen Labs Acetaminophen | ACETAMINOPHEN | Advanced Rx LLC | 474580af-f6b0-e440-e063-6394a90aaada | 2025-12-31 | Warnings | M013 |
| Liquid Acetaminophen | ACETAMINOPHEN | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | a7dbd4c0-53eb-4368-917b-1432c09ce6b4 | 2025-12-31 | Warnings | M013 |
| Llorens Care Children Acetaminophen | ACETAMINOPHEN | Llorens Pharmaceutical International Division, Inc. | 2a46d7d2-293b-5024-e063-6294a90a31aa | 2025-12-31 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN CAPSULES 500MG (MINIS-RED OPAQUE) | Walgreens | 3a801457-c5d0-b134-e063-6294a90ac5cb | 2025-12-31 | Warnings | M013 |
| Daytime and Nighttime Severe Cold and Flu combo pack | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Genexa Inc. | 190c7eaf-dcd4-d314-e063-6294a90a6f33 | 2025-12-30 | Warnings | M013 |
| BioElectro Extra Strength Headache Relief | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Genomma Lab USA | 683a0fba-921c-48e7-a391-180c04f0d1c4 | 2025-12-30 | Warnings | M013 |
| Pain Relief PM | ACETAMINOPHEN, DIPHENHYDRAMINE | Pioneer Life Sciences, LLC | 0181af13-da32-4431-be39-c31fdfac9202 | 2025-12-29 | Warnings | M013 |
| Gemma Cut the Cramp | ASPIRIN, CAFFEINE | Rally Labs LLC | 16c9a296-077a-8e12-e063-6294a90a1b8b | 2025-12-29 | Warnings | M013 |
| Blowfish | ASPIRIN, CAFFEINE | Rally Labs LLC | 0d3798bc-04ef-584e-821b-7aa76036b7d1 | 2025-12-29 | Warnings | M013 |
| Pain Relief PM | ACETAMINOPHEN, DIPHENHYDRAMINE | Pioneer Life Sciences, LLC | ad29a37f-39a2-5c84-e053-2995a90a2f39 | 2025-12-29 | Warnings | M013 |
| Tension Headache Relief | ACETAMINOPHEN, CAFFEINE | Pioneer Life Sciences, LLC | ac9efd62-8fee-b777-e053-2995a90a3783 | 2025-12-29 | Warnings | M013 |
| Childrens Pain Relief and Fever Reducer Oral Suspension Cherry | ACETAMINOPHEN | Puro Pharma Inc. | a2afaee7-19f3-4a42-a5b8-1d0ef3ecf009 | 2025-12-27 | Warnings | M013 |
| Cystex PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Clarion Brands, LLC | 9668a2ca-729e-4172-80b5-33e6c5175ba4 | 2025-12-27 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2626726 | aspirin 650 MG / caffeine 65 MG Oral Powder | PSN | f1fecbb0-5b55-fe8f-e053-2995a90a0977 | 10 |
| 2626726 | aspirin 650 MG / caffeine 65 MG Oral Powder | SCD | f1fecbb0-5b55-fe8f-e053-2995a90a0977 | 10 |
| 2626726 | ASA 650 MG / caffeine 65 MG Oral Powder | SY | f1fecbb0-5b55-fe8f-e053-2995a90a0977 | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0280-0103-01 | 00280010301 | 1 PACKET in 1 CARTON (0280-0103-01) / 10 POWDER in 1 PACKET | 1 packet | 2023-01-13 | No | No | Current |
| 0280-0103-02 | 00280010302 | 1 PACKET in 1 CARTON (0280-0103-02) / 20 POWDER in 1 PACKET | 1 packet | 2023-01-13 | No | No | Current |
| 0280-0103-03 | 00280010303 | 1 PACKET in 1 CARTON (0280-0103-03) / 30 POWDER in 1 PACKET | 1 packet | 2023-01-13 | No | No | Current |